Format

Send to:

Choose Destination
See comment in PubMed Commons below
Vasc Health Risk Manag. 2013;9:303-19. doi: 10.2147/VHRM.S44499. Epub 2013 Jun 17.

Statins in heart failure: do we need another trial?

Author information

  • 1School of Medicine and Health Sciences, Monash University Sunway Campus, Bandar Sunway, Malaysia.

Abstract

Statins lower serum cholesterol and are employed for primary and secondary prevention of cardiovascular events. Clinical evidence from observational studies, retrospective data, and post hoc analyses of data from large statin trials in various cardiovascular conditions, as well as small scale randomized trials, suggest survival and other outcome benefits for heart failure. Two recent large randomized controlled trials, however, appear to suggest statins do not have beneficial effects in heart failure. In addition to lowering cholesterol, statins are believed to have many pleotropic effects which could possibly influence the pathophysiology of heart failure. Following the two large trials, evidence from recent studies appears to support the use of statins in heart failure. This review discusses the role of statins in the pathophysiology of heart failure, current evidence for statin use in heart failure, and suggests directions for future research.

KEYWORDS:

comorbidity; heart failure; mortality; statins; treatment

PMID:
23807852
[PubMed - indexed for MEDLINE]
PMCID:
PMC3688443
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Write to the Help Desk